InvestorsHub Logo
Followers 59
Posts 7372
Boards Moderated 0
Alias Born 10/20/2014

Re: Hamoa post# 214349

Saturday, 09/14/2019 12:09:16 PM

Saturday, September 14, 2019 12:09:16 PM

Post# of 424150
Hamoa, Thank you once again for your well reasoned response.
Although AMRN is well prepared to GIA I believe that revenues
would ultimately be substantially higher under the BP flag. The
resistance by many doctors to prescribe Vascepa lead me to believe
that it would be looked upon as a serious medication if it were
owned by a BP "name" such as JNJ, PFE, NVS, or AMGN. Very few
doctors know what Amarin is...every doctor should know the major
BP's. Vascepa may have to be detailed by sales reps for up to
2 years in some cases before they begin to use it. Regardless,
if JT & company really believed they should become a BP I doubt
if they would have sold as much stock as they have. "If" the
right BO offer comes along I think JT will take it. I wish I
knew what he would consider to be right offer!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News